Keystone Resort Floorplan
Registered Attendees
Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting
(You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
- Full participant list, including joint meeting participants
- Printable Invoices and Invitation Letters
- Scholarship Information
- Lodging Information
Login to My Account page
This meeting took place in 2017
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
RNA-Based Approaches in Cardiovascular Disease (X8)
Organizer(s) Thomas Thum and Roger J. Hajjar
March 26—30, 2017
Keystone Resort • Keystone, CO USA
Discounted Abstract Deadline: Nov 30, 2016
Abstract Deadline: Jan 11, 2017
Scholarship Deadline: Nov 30, 2016
Discounted Registration Deadline: Jan 26, 2017
Sponsored by AstraZeneca
Joint Meeting:
Molecular Mechanisms of Heart Development (X7)
Summary of Meeting:
Cardiac diseases are the leading cause of death worldwide. RNA-based mechanisms and therapeutic approaches are emerging fields in cardiovascular science. This meeting will present and discuss latest developments using both coding RNA and noncoding RNA (such as microRNAs, long noncoding RNAs and circular RNAs) -based approaches to better understand and develop new therapeutic strategies for cardiac diseases. Attendees will benefit from workshops, specific sessions and industrial perspectives covering everything from basic science to clinical translation employing RNA therapeutics in cardiovascular medicine.
View Scholarships/Awards
Cardiac diseases are the leading cause of death worldwide. RNA-based mechanisms and therapeutic approaches are emerging fields in cardiovascular science. This meeting will present and discuss latest developments using both coding RNA and noncoding RNA (such as microRNAs, long noncoding RNAs and circular RNAs) -based approaches to better understand and develop new therapeutic strategies for cardiac diseases. Attendees will benefit from workshops, specific sessions and industrial perspectives covering everything from basic science to clinical translation employing RNA therapeutics in cardiovascular medicine.
View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference
The meeting will begin on Sunday, March 26 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 30 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, March 31 in order to fully experience the meeting.
SUNDAY, MARCH 26
MONDAY, MARCH 27
TUESDAY, MARCH 28
WEDNESDAY, MARCH 29
THURSDAY, MARCH 30
FRIDAY, MARCH 31
Conference Program Print | View meeting in 24 hr (international) time
The meeting will begin on Sunday, March 26 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 30 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, March 31 in order to fully experience the meeting.
SUNDAY, MARCH 26
6:00—8:00 PM
Welcome Mixer
No registration fees are used to fund alcohol served at this function.
8:00—9:00 AM
Welcome and Keynote Address (Joint)
*
Benoit G. Bruneau,
Gladstone Institutes, USA
*
Thomas Thum,
Medical School Hannover, Germany
Eric N. Olson,
University of Texas Southwestern Medical Center, USA
Following the Heart
Following the Heart
9:00—11:15 AM
Common RNA-Based Mechanisms in Cardiovascular Development and Pathology (Joint)
*
Benoit G. Bruneau,
Gladstone Institutes, USA
*
Thomas Thum,
Medical School Hannover, Germany
Stefanie Dimmeler,
University of Frankfurt, Germany
Non-coding RNAs in Cardiovascular Repair and Aging
Non-coding RNAs in Cardiovascular Repair and Aging
Coffee Break
William C. Sessa,
Yale University School of Medicine, USA
Vascular Therapeutics Approaches using miRNAs
Vascular Therapeutics Approaches using miRNAs
Laurie A. Boyer,
Massachusetts Institute of Technology, USA
Long Noncoding RNAs in Heart Development and Differentiation
Long Noncoding RNAs in Heart Development and Differentiation
Tilman Ziegler,
Klinikum rechts der Isar der TU München, Germany
Short Talk: LNA Mediated Inhibition of miR-132 Prevents Hypertrophy Induced Cardiomyopathy in Pigs
Short Talk: LNA Mediated Inhibition of miR-132 Prevents Hypertrophy Induced Cardiomyopathy in Pigs
2:30—4:30 PM
Workshop 1: Basic and Novel Tools for RNA Research
*
Carlos Fernandez-Hernando,
Yale School of Medicine, USA
*
Leon Johannes De Windt,
Maastricht University, Netherlands
Esther E. Creemers,
Academic Medical Center, Netherlands
Circular RNA Profiling and Implications for Cardiac Disease
Circular RNA Profiling and Implications for Cardiac Disease
Mark Mercola,
Stanford University, USA
High Throughput Screening as a Massive Omics Approach to Understand the Heart
High Throughput Screening as a Massive Omics Approach to Understand the Heart
Lior Zangi,
Icahn School of Medicine at Mount Sinai, USA
Gene Therapy Approach for Cardiac Regeneration using Modified mRNA
Gene Therapy Approach for Cardiac Regeneration using Modified mRNA
Cristina Espinosa-Diez,
Oregon Health and Science University, USA
A MicroRNA Regulated Incoherent Feedforward Loop Drives Vascular Senescence
A MicroRNA Regulated Incoherent Feedforward Loop Drives Vascular Senescence
2:30—4:30 PM
Workshop 1: Gene Regulatory Mechanisms
*
Eric Small,
University of Rochester, USA
Nicole Schlüßler,
Goethe University Frankfurt, Germany
A LncRNA Locus in the Genomic Region of Hand2 is Essential for Cardiac Development
A LncRNA Locus in the Genomic Region of Hand2 is Essential for Cardiac Development
Alexandre R. Colas,
Sanford-Burnham Medical Research Institute, USA
Id Genes Are Essential For Early Heart Formation
Id Genes Are Essential For Early Heart Formation
Sunil K. Verma,
University of Texas Medical Branch, USA
Role of the RNA Binding Protein Rbfox2 in Hypoplastic Left Heart Syndrome
Role of the RNA Binding Protein Rbfox2 in Hypoplastic Left Heart Syndrome
Christian Mosimann,
University of Zürich, Switzerland
An Ancient Regulatory Program Controls the Emergence of Cardiogenic Lateral Plate Mesoderm
An Ancient Regulatory Program Controls the Emergence of Cardiogenic Lateral Plate Mesoderm
Li Qian,
University of North Carolina at Chapel Hill, USA
Single Cell Transcriptomics Reveals a Deterministic Trajectory of Cell Fate Conversion during Direct Cardiac Reprogramming
Single Cell Transcriptomics Reveals a Deterministic Trajectory of Cell Fate Conversion during Direct Cardiac Reprogramming
Min Zhang,
Shanghai Children's Medical Center, China
Atrial Fibrillation-Associated Functional Element Regulates Pitx2 Expression via CTCF-Mediated Long-Range Interaction
Atrial Fibrillation-Associated Functional Element Regulates Pitx2 Expression via CTCF-Mediated Long-Range Interaction
5:00—7:15 PM
Fundamentals in RNA Diagnostics and Paracrine Effects
*
Manuel Mayr,
King's College, University of London, UK
*
Susmita Sahoo,
Icahn School of Medicine at Mount Sinai, USA
Carlos Fernandez-Hernando,
Yale School of Medicine, USA
Noncoding RNAs as Paracrine Players in Vascular Inflammation and Lipid Metabolism
Noncoding RNAs as Paracrine Players in Vascular Inflammation and Lipid Metabolism
Denise Hilfiker-Kleiner,
Medizinische Hochschule Hannover, Germany
Pathophysiology of Peripartum Cardiomyopathy Links Prolactin to the PAI-1/uPAR System: Modulation of NF-kB Signaling and miR146a as Therapeutic Options
Pathophysiology of Peripartum Cardiomyopathy Links Prolactin to the PAI-1/uPAR System: Modulation of NF-kB Signaling and miR146a as Therapeutic Options
Paula da Costa Martins,
Maastricht University, Netherlands
Short Talk: Cardiomyocyte-Derived Exosomes Mediate Pathological Cardiac Microvascular Remodeling
Short Talk: Cardiomyocyte-Derived Exosomes Mediate Pathological Cardiac Microvascular Remodeling
Yuri D'Alessandra,
Centro Cardiologico Monzino, Italy
Short Talk: Circulating MicroRNAs as Biomarkers of Long-Term Doxorubicin-Induced Cardiotoxicity
Short Talk: Circulating MicroRNAs as Biomarkers of Long-Term Doxorubicin-Induced Cardiotoxicity
Stefanie Novakowski,
University of British Columbia, Canada
Short Talk: Engineering Platelets for the Delivery of RNA
Short Talk: Engineering Platelets for the Delivery of RNA
Christa L. Trexler,
University of Colorado Boulder, USA
Short Talk: Cardiomyocyte Function and Gene Expression are Influenced by Biological Sex
Short Talk: Cardiomyocyte Function and Gene Expression are Influenced by Biological Sex
5:00—7:00 PM
Cardiac Lineages
*
Kristy Red-Horse,
Stanford University, USA
Margaret E. Buckingham,
Institut Pasteur, France
Cardiac Cell Lineages and the Second Heart Field
Cardiac Cell Lineages and the Second Heart Field
Lionel Christiaen,
New York University, USA
Regulation of Cardiopharyngeal Multipotency and Early Fate Specification in a Simple Chordate
Regulation of Cardiopharyngeal Multipotency and Early Fate Specification in a Simple Chordate
Caroline E. Burns,
Harvard Medical School, Boston Children's Hospital, USA
Development of the Cardiopharyngeal Lineage in Zebrafish
Development of the Cardiopharyngeal Lineage in Zebrafish
Nicole Dubois,
Icahn School of Medicine at Mount Sinai, USA
Short Talk: Foxa2 Marks a Ventricular Progenitor Population during Heart Development
Short Talk: Foxa2 Marks a Ventricular Progenitor Population during Heart Development
7:15—8:15 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
8:00—8:45 AM
Keynote Address
*
Roger J. Hajjar,
Mount Sinai School of Medicine, USA
*
Gerald W. Dorn, II,
Washington University School of Medicine, USA
Manuel Mayr,
King's College, University of London, UK
A Systems Biology Approach: Circulating Noncoding RNAs as Innovative Diagnostic and Prognostic Markers of Cardiovascular Disease
A Systems Biology Approach: Circulating Noncoding RNAs as Innovative Diagnostic and Prognostic Markers of Cardiovascular Disease
8:45 AM—12:00 PM
Noncoding RNA Therapeutics: What Have We Learned?
*
Roger J. Hajjar,
Mount Sinai School of Medicine, USA
*
Gerald W. Dorn, II,
Washington University School of Medicine, USA
Susmita Sahoo,
Icahn School of Medicine at Mount Sinai, USA
Exosomes as a Diagnostic and Therapeutic Tool in Cardiovascular Disease
Exosomes as a Diagnostic and Therapeutic Tool in Cardiovascular Disease
Coffee Break
Eva van Rooij,
Hubrecht Institute, Netherlands
Advances in Targeting miRNAs in the Heart
Advances in Targeting miRNAs in the Heart
Gianluigi Condorelli,
Humanitas University, Italy
Chheaf1: A Novel lncRNA Regulating Cardiac Hypertrophy and Failure
Chheaf1: A Novel lncRNA Regulating Cardiac Hypertrophy and Failure
Elizabeth M. McNally,
Northwestern University, USA
Targeting Muscular Dystrophy
Targeting Muscular Dystrophy
Robin Verjans,
Maastricht University, Netherlands
Short Talk: Downregulation of the microRNA-221/222 Family Upon Heart Failure Contributes to Adverse Cardiac Fibrotic Remodeling
Short Talk: Downregulation of the microRNA-221/222 Family Upon Heart Failure Contributes to Adverse Cardiac Fibrotic Remodeling
Christine Wahlquist,
Stanford University, USA
Short Talk: Modulation of Cardiomyocyte Physiology by Stretch-Induced miRNAs
Short Talk: Modulation of Cardiomyocyte Physiology by Stretch-Induced miRNAs
8:00—11:00 AM
Epicardium and Coronaries
*
Kelly Smith,
University of Queensland, Australia
Kenneth D. Poss,
Duke University Medical Center, USA
Cardiac Regeneration
Cardiac Regeneration
Coffee Break
Bin Zhou,
Albert Einstein College of Medicine, USA
Developmental Mechanisms of Coronary Artery Formation
Developmental Mechanisms of Coronary Artery Formation
Michael A. Trembley,
University of Rochester Medical Center, USA
Short Talk: Novel Mechanisms of Epicardial-Derived Cell Mobilization
Short Talk: Novel Mechanisms of Epicardial-Derived Cell Mobilization
5:00—7:00 PM
Novel Approaches in RNA Detection and Networks
*
Gianluigi Condorelli,
Humanitas University, Italy
*
Christian Kupatt,
Technical University Munich, Germany
Stefan Engelhardt,
Technical University of Munich, Germany
Approaches to Identify Crucial miRNA Mechanisms of Action
Approaches to Identify Crucial miRNA Mechanisms of Action
Arthur A. Levin,
Avidity Biosciences, USA
Toxicological Considerations in Oligonucleotide Therapeutics Development
Toxicological Considerations in Oligonucleotide Therapeutics Development
Anne Katrine Johansen,
Hubrecht Institute, Netherlands
Short Talk: CRISPR/Cas9-based Postnatal Gene Editing to Study Cardiac Gene Function in vivo
Short Talk: CRISPR/Cas9-based Postnatal Gene Editing to Study Cardiac Gene Function in vivo
Prabhu Mathiyalagan,
Icahn School of Medicine at Mount Sinai, USA
Short Talk: Dynamic Regulation of m6A RNA methylation is a Novel Remodeling Mechanism of the Ischemic Heart
Short Talk: Dynamic Regulation of m6A RNA methylation is a Novel Remodeling Mechanism of the Ischemic Heart
5:00—7:00 PM
Gene Regulatory Mechanisms
*
Laurie A. Boyer,
Massachusetts Institute of Technology, USA
Vincent M. Christoffels,
Academic Medical Center, Netherlands
Transcriptional Regulation of the Electrical Activity Pattern of the Heart
Transcriptional Regulation of the Electrical Activity Pattern of the Heart
Benoit G. Bruneau,
Gladstone Institutes, USA
Transcriptional Regulation of Heart Development
Transcriptional Regulation of Heart Development
Brian L. Black,
University of California, San Francisco, USA
Cooperative Activation of Cardiac Transcription through Myocardin Bridging of Paired MEF2 Sites
Cooperative Activation of Cardiac Transcription through Myocardin Bridging of Paired MEF2 Sites
Rangarajan Nadadur,
University of Chicago, USA
Short Talk: Differential Enhancer Transcription Defines a Disease-Associated Gene Regulatory Network
Short Talk: Differential Enhancer Transcription Defines a Disease-Associated Gene Regulatory Network
7:15—8:15 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
8:00—11:00 AM
Non-Coding RNAs Going Looooong . . .
*
Stefan Engelhardt,
Technical University of Munich, Germany
Gerald W. Dorn, II,
Washington University School of Medicine, USA
Orchestration of Smoothened/Hedgehog/GATA Transcriptional Activity by GRKs 2, 5, and 6 in Developing Mouse Hearts
Orchestration of Smoothened/Hedgehog/GATA Transcriptional Activity by GRKs 2, 5, and 6 in Developing Mouse Hearts
Yibin Wang,
University of California, Los Angeles, David Geffen School of Medicine, USA
A lncRNA-Dependent Epigenetic Check-Point for Cardiac Hypertrophy and Remodeling
A lncRNA-Dependent Epigenetic Check-Point for Cardiac Hypertrophy and Remodeling
Coffee Break
Venkata Naga Srikanth Garikipati,
Temple University, USA
Short Talk: Long Noncoding Circular RNA mmu_circ_008396 Modulates Cardiac Repair After Myocardial Infarction
Short Talk: Long Noncoding Circular RNA mmu_circ_008396 Modulates Cardiac Repair After Myocardial Infarction
Da-Zhi Wang,
Children's Hospital Boston, USA
Short Talk: Genome-Wide Identification and Characterization of Cardiac Hypertrophy-Related Long Noncoding RNAs
Short Talk: Genome-Wide Identification and Characterization of Cardiac Hypertrophy-Related Long Noncoding RNAs
Samir Ounzain,
HAYA Therapeutics, Switzerland
Short Talk: Transposable Elements Contribute to the Functional and Regulatory Characteristics of Cardiovascular lncRNAs
Short Talk: Transposable Elements Contribute to the Functional and Regulatory Characteristics of Cardiovascular lncRNAs
8:00—11:00 AM
Congenital Heart Disease: Genes and Pathways
*
Vincent M. Christoffels,
Academic Medical Center, Netherlands
Christine E. Seidman,
Harvard Medical School, USA
Steps and Missteps in Building the Heart
Steps and Missteps in Building the Heart
Ivan P. Moskowitz,
University of Chicago, USA
A Timing Switch for Cardiac Progenitor Differentiation
A Timing Switch for Cardiac Progenitor Differentiation
Coffee Break
William T. Pu,
Children's Hospital, Harvard Medical School, USA
iPSC-CM Models of Congenital Heart Disease
iPSC-CM Models of Congenital Heart Disease
Richard P. Harvey,
University of New South Wales, Victor Chang Cardiac Research Institute, Australia
Transcriptional Targets and Off-Targets in Congenital Heart Disease
Transcriptional Targets and Off-Targets in Congenital Heart Disease
Zhe Han,
Children's National Health System, USA
Short Talk: High Throughput in vivo Functional Validation of Candidate Congenital Heart Disease Genes in Drosophila
Short Talk: High Throughput in vivo Functional Validation of Candidate Congenital Heart Disease Genes in Drosophila
5:00—7:15 PM
Preclinical Approaches Using RNA Therapeutics
*
Yibin Wang,
University of California, Los Angeles, David Geffen School of Medicine, USA
*
Patrick Most,
University of Heidelberg, Germany
Rusty Montgomery,
miRagen Therapeutics, Inc., USA
Pharmacokinetic/Dynamic Aspects of Oligonucleotide Therapeutics
Pharmacokinetic/Dynamic Aspects of Oligonucleotide Therapeutics
Christian Kupatt,
Technical University Munich, Germany
Micro-RNAs based Therapeutics in Porcine Cardiac Disease Models
Micro-RNAs based Therapeutics in Porcine Cardiac Disease Models
Rabea Hinkel,
Klinikum rechts der Isar, TUM, Germany
Short Talk: Cardio-Protective Potential of miR-92a Inhibition in Myocardial Ischemia
Short Talk: Cardio-Protective Potential of miR-92a Inhibition in Myocardial Ischemia
Dongtak Jeong,
Ichan School of Medicine at Mount Sinai, USA
Short Talk: AAV9 miR-25 Tough Decoy Transfer Improves Cardiac Function in HF and Aged MDX/UTRN KO Mice
Short Talk: AAV9 miR-25 Tough Decoy Transfer Improves Cardiac Function in HF and Aged MDX/UTRN KO Mice
Adam E. Mullick,
Ionis Pharmaceuticals, Inc., USA
Short Talk: Characterization of Cardiac Gen 2.5 Antisense Oligonucleotide Activity
Short Talk: Characterization of Cardiac Gen 2.5 Antisense Oligonucleotide Activity
Deepak Prabhu Ramanujam,
Institute of Pharmakologie und Toxikologie, Technische Universitaet Muenchen, Germany
Short Talk: Inhibition of microRNA-21 Prevents Myocardial Remodeling in a Pig Model of Ischemia/Reperfusion Injury
Short Talk: Inhibition of microRNA-21 Prevents Myocardial Remodeling in a Pig Model of Ischemia/Reperfusion Injury
5:00—7:00 PM
Mechanisms of Cardiac Growth and Morphogenesis
*
Caroline E. Burns,
Harvard Medical School, Boston Children's Hospital, USA
Anthony B. Firulli,
Wells Center for Pediatrics Research, USA
Characterization of a Hand1 Left Ventricular Enhancer and Development of a Left Ventricular Specific Cre Driver
Characterization of a Hand1 Left Ventricular Enhancer and Development of a Left Ventricular Specific Cre Driver
Katherine E. Yutzey,
Cincinnati Children's Hospital Medical Center, USA
Developmental Mechanisms of Heart Valve Disease
Developmental Mechanisms of Heart Valve Disease
James F. Martin,
Baylor College of Medicine, USA
The Hippo Pathway in Heart Development and Regeneration
The Hippo Pathway in Heart Development and Regeneration
Daniela Panakova,
Max Delbrück Center for Molecular Medicine, Germany
Short Talk: Planar Cell Polarity Pathway Links Mechanosensitive Feedback between Cardiac Remodeling and Muscle Differentiation
Short Talk: Planar Cell Polarity Pathway Links Mechanosensitive Feedback between Cardiac Remodeling and Muscle Differentiation
7:15—8:15 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
8:00—11:00 AM
Mechanisms of Cardiovascular Regeneration (Joint)
*
Mauro Giacca,
International Center for Genetic Engineering, Italy
Deepak Srivastava,
Gladstone Institutes, USA
Cellular Reprogramming Approaches for Cardiovascular Disease
Cellular Reprogramming Approaches for Cardiovascular Disease
Nadia Mercader,
Institut of Anatomy, University of Bern, Switzerland
Plasticity of Cardiomyocyte Fate during Heart Regeneration in Zebrafish
Plasticity of Cardiomyocyte Fate during Heart Regeneration in Zebrafish
Coffee Break
Andrew H. Baker,
University of Edinburgh, UK
Non Coding RNA Therapeutics in Cardiovascular Pathophysiology
Non Coding RNA Therapeutics in Cardiovascular Pathophysiology
Chen Gao,
University of California, Los Angeles, USA
Short Talk: Cytosolic RBFox1 In Cardiac Fibrosis Regulation
Short Talk: Cytosolic RBFox1 In Cardiac Fibrosis Regulation
2:30—4:30 PM
Workshop 2: Cardiovascular Repair Mechanisms (Joint)
*
Masaki Ieda,
Keio University School of Medicine, Japan
*
Eva van Rooij,
Hubrecht Institute, Netherlands
Monika M. Gladka,
Hubrecht Institute, Netherlands
Zeb2 Protects the Heart from Ischemic Damage
Zeb2 Protects the Heart from Ischemic Damage
Ajit Magadum,
Icahn School of Medicine, Mount Sinai Hospital, USA
Cardiomyocyte-Specific Expression of Cell Cycle Inducer modRNA Induces Cardiac Regeneration
Cardiomyocyte-Specific Expression of Cell Cycle Inducer modRNA Induces Cardiac Regeneration
Shin Watanabe,
Icahn School of Medicine at Mount Sinai, USA
miR-146a Regulates Cardiac Function by Targeting SUMO1/SERCA2a Pathway
miR-146a Regulates Cardiac Function by Targeting SUMO1/SERCA2a Pathway
Lina A. Shehadeh,
University of Miami Miller School of Medicine, USA
Osteopontin RNA Aptamer Can Prevent and Reverse Pressure Overload-Induced Heart Failure
Osteopontin RNA Aptamer Can Prevent and Reverse Pressure Overload-Induced Heart Failure
C. Geoffrey Burns,
Harvard Medical School, Massachusetts General Hospital, USA
Cardiomyocyte Polyploidization Creates a Barrier to Heart Regeneration in Zebrafish
Cardiomyocyte Polyploidization Creates a Barrier to Heart Regeneration in Zebrafish
Honghai Liu,
Children's Hospital of Pittsburgh of UPMC, USA
Repression of Epithelial Cell Transforming 2 (Ect2) Induces Binucleation of Cardiomyocytes
Repression of Epithelial Cell Transforming 2 (Ect2) Induces Binucleation of Cardiomyocytes
Thomas J. Cahill,
University of Oxford, UK
Macrophages Activate Distinct Programs of Regeneration and Scar Formation to Direct Repair following Myocardial Infarction
Macrophages Activate Distinct Programs of Regeneration and Scar Formation to Direct Repair following Myocardial Infarction
Hamid el Azzouzi,
Maastricht University, Netherlands
Targeted Deletion of ADAR1 in the Adult Heart Causes Severe Cardiac Dysfunction and Increased Lethality
Targeted Deletion of ADAR1 in the Adult Heart Causes Severe Cardiac Dysfunction and Increased Lethality
5:00—6:45 PM
RNA Therapeutics in Clinical Translation
*
Wolfram H. Zimmermann,
University Medical Center Göttingen, Germany
Roger J. Hajjar,
Mount Sinai School of Medicine, USA
Gene Therapy and Genome Editing for Heart Failure
Gene Therapy and Genome Editing for Heart Failure
Patrick Most,
University of Heidelberg, Germany
Development of Nucleic-Acid Therapeutics for Cardiac and Vascular Disorder Treatment
Development of Nucleic-Acid Therapeutics for Cardiac and Vascular Disorder Treatment
Mauro Giacca,
International Center for Genetic Engineering, Italy
Small RNA Therapy for Cardiac Regeneration
Small RNA Therapy for Cardiac Regeneration
5:00—6:45 PM
Modeling Human Heart Development
*
Benoit G. Bruneau,
Gladstone Institutes, USA
Christine L. Mummery,
Leiden University Medical Center, Netherlands
Developmental Patterning of Human Pluripotent Stem Cells: From Beating Cardiomycoytes to Heart Disease Models
Developmental Patterning of Human Pluripotent Stem Cells: From Beating Cardiomycoytes to Heart Disease Models
Charles E. Murry,
University of Washington, USA
Networks Underlying Human Cardiovascular Differentiation
Networks Underlying Human Cardiovascular Differentiation
Gordon M. Keller,
University Health Network, MaRS Centre, Canada
Modeling Cardiovascular Development with Human Pluripotent Stem Cells
Modeling Cardiovascular Development with Human Pluripotent Stem Cells
7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
8:00—11:00 PM
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.
*Session Chair †Invited, not yet responded.
We gratefully acknowledge support for this conference from:
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
|
|
We gratefully acknowledge the generous grant for this conference provided by:
We gratefully acknowledge additional support for this conference from:
|
|
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
|
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: Sarah Lavicka,
Director of Corporate Relations, Email: sarahl@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org, Phone:+1 970-262-1179 |
